Who are the key players in the Imfinzi (durvalumab) Market Report 2026 market?

Major companies operating in the Imfinzi (durvalumab) Market Report 2026 market are Major companies operating in the imfinzi (durvalumab) market are AstraZeneca PLC. Read More

What are the major opportunities in the Imfinzi (durvalumab) market? What are the strategies for the Imfinzi (durvalumab) market?

For detailed insights on the major opportunities and strategies in the Imfinzi (durvalumab) market, Read More

How does the Imfinzi (durvalumab) market relate to the overall economy and other similar markets?

For detailed insights on Imfinzi (durvalumab)'s relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Imfinzi (durvalumab) industry?

For detailed insights on the mergers and acquisitions in the Imfinzi (durvalumab) industry, Read More

What are the key dynamics influencing the Imfinzi (durvalumab) market growth? SWOT analysis of the Imfinzi (durvalumab) market.

For detailed insights on the key dynamics influencing the Imfinzi (durvalumab) market growth and SWOT analysis of the Imfinzi (durvalumab) industry, Read More

Imfinzi (durvalumab) Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Imfinzi (durvalumab) Market Report 2026

Name: Imfinzi (durvalumab) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (2.4mL Injection, 10mL Injection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Imfinzi (durvalumab) Market Overview

• The Imfinzi (durvalumab) market growth in the historic period has been driven by clinical success of immune checkpoint inhibitors, rising lung cancer prevalence

• Market expansion is supported by expansion into new cancer indications, increased immunotherapy accessibility

• Growth Driver: Impact Of Rising Cancer Incidence On The Future Growth Of The Avelumab Market

• Market Trend: Perioperative Immunotherapy Expansion Driving Competitive Differentiation In Advanced Oncology Care

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Imfinzi (durvalumab) Market?

Imfinzi (durvalumab) is a human monoclonal antibody and an immunotherapy drug specifically designed to block programmed death-ligand 1 (PD-L1), a protein that tumors use to evade detection by the immune system. It is used to treat various cancers, including non-small cell lung cancer, small cell lung cancer, biliary tract cancer, and advanced urothelial carcinoma.

The main types of Imfinzi (durvalumab) are 2.4 mL injection and 10 mL injection. A 2.4 mL injection refers to a specific volume of a medication or therapeutic substance contained in a 2.4 milliliter (mL) vial or syringe, typically used for precise dosing in medical treatments or procedures. It can be distributed through hospital pharmacies, retail pharmacies, and online pharmacies for various applications, including locally advanced urothelial carcinoma, metastatic urothelial carcinoma, and others.

Imfinzi (durvalumab) Market Global Report 2026 Market Report bar graph

What Is The Imfinzi (durvalumab) Market Size and Share 2026?

The imfinzi (durvalumab) market size has grown rapidly in recent years. It will grow from $3.01 million in 2025 to $3.36 million in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to clinical success of immune checkpoint inhibitors, rising lung cancer prevalence, regulatory approvals in oncology, improved survival outcomes, strong pharmaceutical investment.

What Is The Imfinzi (durvalumab) Market Growth Forecast?

The imfinzi (durvalumab) market size is expected to see rapid growth in the next few years. It will grow to $5.11 million in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to expansion into new cancer indications, increased immunotherapy accessibility, growth in oncology clinical trials, rising healthcare oncology spending, development of combination protocols. Major trends in the forecast period include rising adoption of pd-l1 inhibitors, expansion of immunotherapy in lung cancer, growth of combination immuno oncology regimens, increased focus on biomarker driven therapies, broader use across multiple solid tumors.

Book your 30 minutes free consultation with our research experts

Global Imfinzi (durvalumab) Market Segmentation

1) By Type: 2.4mL Injection, 10mL Injection

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Other Applications

What Are The Drivers Of The Imfinzi (durvalumab) Market?

The growing incidence of cancer is expected to drive the growth of the Imfinzi (durvalumab) market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body, which can invade and destroy normal tissues. The growing incidence of cancer is largely driven by an aging population, as the risk of cancer increases with age, and by lifestyle factors such as smoking, poor diet, and obesity, which contribute to higher cancer rates. Durvalumab (Imfinzi) is used to treat cancer by inhibiting the PD-L1 protein, which prevents cancer cells from evading detection by the immune system. For instance, in May 2024, according to the National Cancer Institute (NIH), a US-based government agency, in 2022, there were 18.1 million cancer survivors in the U.S., expected to rise to 22.5 million by 2032. Therefore, the growing incidence of cancer is driving the growth of the Imfinzi (durvalumab) industry.

Rising personalized medicine is expected to propel the growth of the imfinzi (durvalumab) market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient, such as their genetic makeup, environment, and lifestyle, to achieve the most effective and precise outcomes. The rising personalized medicine is due to advancements in genomic technologies, increased understanding of molecular biology, growing availability of precision diagnostic tools, and the demand for targeted therapies that improve patient outcomes while minimizing side effects. Imfinzi (durvalumab), by targeting and inhibiting the PD-L1 protein, helps personalized medicine by enabling tailored immunotherapy treatments for cancer patients based on the specific tumor biology and immune system characteristics, thereby enhancing treatment efficacy and minimizing unnecessary side effects. For instance, in 2023, according to the Personalized Medicine Coalition, a US-based representative organization, in 2022, the FDA approved personalized medicines for 34% of new drugs, and during the previous eight years, they had been approved for at least 25% of new drugs. Therefore, rising personalized medicine drives the imfinzi (durvalumab) industry.

Key Players In The Global Imfinzi (durvalumab) Market

Major companies operating in the imfinzi (durvalumab) market are AstraZeneca PLC.

Global Imfinzi (durvalumab) Market Trends and Insights

Major companies operating in the Global Imfinzi (durvalumab) market are focusing on indication expansion, such as perioperative use combined with chemotherapy, to gain a competitive advantage. For instance, in January 2023, AstraZeneca plc, a UK based biopharmaceutical company, announced that IMFINZI plus chemotherapy more than doubled pathologic complete response rate in resectable early-stage gastric and gastroesophageal junction cancers versus chemotherapy alone, featuring two phase treatment (pre surgery and post surgery) and a durable immune activation benefit. This broadening into gastrointestinal cancer settings underscores AstraZeneca’s strategy to deepen its clinical footprint and drive long-term uptake. However, this strategy also brings regulatory risk, as the more complex treatment regimens require additional trial data and health economic validation.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the imfinzi (durvalumab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Imfinzi (durvalumab) Market?

The imfinzi (durvalumab) market consists of sales of products including Keytruda, Opdivo, Tecentriq, Libtayo, Bavencio and Emerging PD-1/PD-L1 Inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Imfinzi (durvalumab) Market Report 2026?

The imfinzi (durvalumab) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the imfinzi (durvalumab) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Imfinzi (durvalumab) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	CAGR of 11.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Distribution Channel, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	AstraZeneca PLC.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Imfinzi (durvalumab) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Imfinzi (durvalumab) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Imfinzi (durvalumab) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Imfinzi (durvalumab) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Pd-L1 Inhibitors

4.2.2 Expansion Of Immunotherapy In Lung Cancer

4.2.3 Growth Of Combination Immuno Oncology Regimens

4.2.4 Increased Focus On Biomarker Driven Therapies

4.2.5 Broader Use Across Multiple Solid Tumors

5. Imfinzi (durvalumab) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Cancer Treatment Centers

5.4 Specialty Pharmacies

5.5 Research Institutions

6. Imfinzi (durvalumab) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Imfinzi (durvalumab) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Imfinzi (durvalumab) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Imfinzi (durvalumab) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Imfinzi (durvalumab) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Imfinzi (durvalumab) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Imfinzi (durvalumab) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Imfinzi (durvalumab) Market Segmentation

9.1. Global Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

2.4mL Injection, 10mL Injection

9.2. Global Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.3. Global Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Other Applications

10. Imfinzi (durvalumab) Market Regional And Country Analysis

10.1. Global Imfinzi (durvalumab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Imfinzi (durvalumab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Imfinzi (durvalumab) Market

11.1. Asia-Pacific Imfinzi (durvalumab) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Imfinzi (durvalumab) Market

12.1. China Imfinzi (durvalumab) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Imfinzi (durvalumab) Market

13.1. India Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Imfinzi (durvalumab) Market

14.1. Japan Imfinzi (durvalumab) Market Overview

14.2. Japan Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Imfinzi (durvalumab) Market

15.1. Australia Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Imfinzi (durvalumab) Market

16.1. South Korea Imfinzi (durvalumab) Market Overview

16.2. South Korea Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Imfinzi (durvalumab) Market

17.1. Western Europe Imfinzi (durvalumab) Market Overview

17.2. Western Europe Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Imfinzi (durvalumab) Market

18.1. UK Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Imfinzi (durvalumab) Market

19.1. Germany Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Imfinzi (durvalumab) Market

20.1. France Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Imfinzi (durvalumab) Market

21.1. Eastern Europe Imfinzi (durvalumab) Market Overview

21.2. Eastern Europe Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Imfinzi (durvalumab) Market

22.1. North America Imfinzi (durvalumab) Market Overview

22.2. North America Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Imfinzi (durvalumab) Market

23.1. USA Imfinzi (durvalumab) Market Overview

23.2. USA Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Imfinzi (durvalumab) Market

24.1. Canada Imfinzi (durvalumab) Market Overview

24.2. Canada Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Imfinzi (durvalumab) Market

25.1. South America Imfinzi (durvalumab) Market Overview

25.2. South America Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Imfinzi (durvalumab) Market

26.1. Middle East Imfinzi (durvalumab) Market Overview

26.2. Middle East Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Imfinzi (durvalumab) Market

27.1. Africa Imfinzi (durvalumab) Market Overview

27.2. Africa Imfinzi (durvalumab) Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Imfinzi (durvalumab) Market Regulatory and Investment Landscape

29. Imfinzi (durvalumab) Market Competitive Landscape And Company Profiles

29.1. Imfinzi (durvalumab) Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Imfinzi (durvalumab) Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Imfinzi (durvalumab) Market Company Profiles

29.3.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30. Global Imfinzi (durvalumab) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Imfinzi (durvalumab) Market

32. Imfinzi (durvalumab) Market High Potential Countries, Segments and Strategies

32.1 Imfinzi (durvalumab) Market In 2030 - Countries Offering Most New Opportunities

32.2 Imfinzi (durvalumab) Market In 2030 - Segments Offering Most New Opportunities

32.3 Imfinzi (durvalumab) Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Imfinzi (durvalumab) Market, Overview Of Key Products - Product Examples

Table 2: Global Imfinzi (durvalumab) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Imfinzi (durvalumab) Market, Supply Chain Analysis

Table 4: Global Imfinzi (durvalumab) Market, Major Raw Material Providers

Table 5: Global Imfinzi (durvalumab) Market, Major Resource Providers

Table 6: Global Imfinzi (durvalumab) Market, Major Manufacturers (Suppliers)

Table 7: Global Imfinzi (durvalumab) Market, Major Distributors And Channel Partners

Table 8: Global Imfinzi (durvalumab) Market, Key Technologies & Future Trends

Table 9: Global Imfinzi (durvalumab) Market, Major Trends

Table 10: Global Imfinzi (durvalumab) Market, Major End Users

Table 11: Global Imfinzi (durvalumab) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Imfinzi (durvalumab) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Imfinzi (durvalumab) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Imfinzi (durvalumab) Market - TAM, US$ Billion, 2025

Table 15: Global Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Imfinzi (durvalumab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Imfinzi (durvalumab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Imfinzi (durvalumab) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Imfinzi (durvalumab) Market - Company Scoring Matrix

Table 73: AstraZeneca PLC Financial Performance

Table 74: Global Imfinzi (durvalumab) Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Imfinzi (durvalumab) Market, Competitive Dashboard

Table 76: Global Imfinzi (durvalumab) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Imfinzi (durvalumab) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 78: Global, Imfinzi (durvalumab) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Table 79: Global, Imfinzi (durvalumab) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Imfinzi (durvalumab) Market, Overview Of Key Products - Product Examples

Figure 2: Global Imfinzi (durvalumab) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Imfinzi (durvalumab) Market, Supply Chain Analysis

Figure 4: Global Imfinzi (durvalumab) Market, Major Raw Material Providers

Figure 5: Global Imfinzi (durvalumab) Market, Major Resource Providers

Figure 6: Global Imfinzi (durvalumab) Market, Major Manufacturers (Suppliers)

Figure 7: Global Imfinzi (durvalumab) Market, Major Distributors And Channel Partners

Figure 8: Global Imfinzi (durvalumab) Market, Key Technologies & Future Trends

Figure 9: Global Imfinzi (durvalumab) Market, Major Trends

Figure 10: Global Imfinzi (durvalumab) Market, Major End Users

Figure 11: Global Imfinzi (durvalumab) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Imfinzi (durvalumab) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Imfinzi (durvalumab) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Imfinzi (durvalumab) Market - TAM, US$ Billion, 2025

Figure 15: Global Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Imfinzi (durvalumab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Imfinzi (durvalumab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Imfinzi (durvalumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Imfinzi (durvalumab) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Imfinzi (durvalumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Imfinzi (durvalumab) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Imfinzi (durvalumab) Market - Company Scoring Matrix

Figure 73: AstraZeneca PLC Financial Performance

Figure 74: Global Imfinzi (durvalumab) Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Imfinzi (durvalumab) Market, Competitive Dashboard

Figure 76: Global Imfinzi (durvalumab) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Imfinzi (durvalumab) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 78: Global, Imfinzi (durvalumab) Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Figure 79: Global, Imfinzi (durvalumab) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Market Report 2026 - Global Outlook – By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail...

Autoimmune Disease Diagnosis Market Report 2026 - Global Outlook – By Product (Consumables And Assay Kits, Instruments), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests), By E...

Natural Immune Booster Market Report 2026 - Global Outlook – By Product Type (Herbal Supplements, Vitamins And Minerals, Probiotics, Functional Foods And Beverages, Essential Oils, Other Product Types), By Distribution C...

Hyperimmune Globulins Market Report 2026 - Global Outlook – By Type (Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zost...

Urinary Tract Cancer Market Report 2026 - Global Outlook – By Cancer Type (Bladder Cancer, Urethral Cancer, Ureteric And Renal Pelvic Cancer), By Treatment (Chemotherapy, Intravesical Therapy, Radiation Therapy, Surgery)...

Bladder Cancer Drugs Market Report 2026 - Global Outlook – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer ), By Application (Low-Grade Tumors, High-Grade Tumors ), By Distribution Channel (Ho...

Blood Cancer Drugs Market Report 2026 - Global Outlook – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan Or Mabthera (Rituximab), Gleevec Or Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), ...

Frequently Asked Questions

How big is the Imfinzi (durvalumab) Market?

The Imfinzi (durvalumab) market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Imfinzi (durvalumab) market growth?

The global Imfinzi (durvalumab) market is expected to grow at a CAGR of 11.1% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Imfinzi (durvalumab) market?

Some Key Players in the Imfinzi (durvalumab) market Include, AstraZeneca PLC. .

What is the anticipated growth trend for the Imfinzi (durvalumab) market?

Major trend in this market includes: Perioperative Immunotherapy Expansion Driving Competitive Differentiation In Advanced Oncology Care. For further insights on this market. request a sample here

Which region has the most growth potential in the Imfinzi (durvalumab) market?

North America was the largest region in the imfinzi (durvalumab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the imfinzi (durvalumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.